Protein could lead to prostate cancer vaccine

Scientists have uncovered a protein which could trigger the body’s immune system in fighting prostate cancer tumours — raising hopes of a new vaccine to help combat the deadly disease.

Protein could lead to prostate cancer  vaccine

Researchers at Nottingham Trent University have identified characteristics in a protein which may not only be able to stimulate the body’s own defences to attack tumour cells, but which could also help protect from established prostate tumours — bringing new hope to those with an advanced form of the disease.

Their study has focused on the protein called prostatic acid phosphatase (PAP), which occurs in 90% of prostate tumours, and specifically dealt with using a part of PAP, called PAP 114.

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €130 €65

Best value

Monthly €12€6 / month

More in this section

Lunchtime News

Newsletter

Keep up with stories of the day with our lunchtime news wrap and important breaking news alerts.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited